Mehmet Nail Bilen

Mehmet Nail Bilen


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MBMehmet Nail Bilen
Mehmet Nail Bilen
ÖGÖmer Genç
Ömer Genç
GÇGazi Çapar
Gazi Çapar
MGMuhammed mert Göksu
Muhammed mert Göksu
HAHüseyin Akgün
Hüseyin Akgün
EİErsin İbişoğlu
Ersin İbişoğlu
Background: To investigate the association between the uric acid-to-high-density lipoprotein cholesterol ratio (UAHDLr) and the risk of new-onset atrial fibrillation (NOAF) during hospitalization in patients with non-ST-elevation myocardial infarction (NSTEMI). Methods: This retrospective cohort study included NSTEMI patients without prior atrial fibrillation. UAHDLr was log2-transformed to evaluate the effect of doubling. Feature selection was performed using least absolute shrinkage and selection operator regression. Cox proportional hazards models with sequential adjustments were applied. Nonlinear associations were assessed using restricted cubic spline analysis, and discrimination was evaluated with time-dependent receiver operating characteristic analysis. Results: UAHDLr was independently associated with in-hospital NOAF across all models. Doubling (1-unit increase) UAHDLr significantly increased NOAF risk in unadjusted (HR: 5.97, 95% CI: 3.71–9.61) and clinically adjusted models (HR: 5.98, 95% CI: 3.58–9.99). The association was stronger in the LASSO-adjusted (HR: 8.19, 95% CI: 4.13–16.24) and fully adjusted models (HR: 13.40, 95% CI: 5.90–30.44). Spline analysis showed a progressive increase in NOAF risk with higher UAHDLr values. Discrimination was stable, with an area under the curve of approximately 0.76. Conclusions: UAHDLr is a strong, easily accessible biomarker for predicting in-hospital NOAF in NSTEMI patients and may support early risk stratification.